Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy.
Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy.
复制标题
DOI:
10.3109/08830185.2014.954699
复制
发表时间:
2014-10
影响因子:
5
通讯作者:
Shifrin VI
中科院分区:
文献类型:
--
作者:
Gabai VL;Shifrin VI
Cancer immunotherapy is a thriving field, but its clinical achievements are modest so far. One of its major hurdles seems to be finding a feasible cancer antigen as a target for immune response. After many years of research, three major criteria for choice of tumor antigens emerged. An antigen should be: (i) immunogenic; (ii) essential for cancers cells (to avoid its loss through immunoediting), but dispensable for normal tissues to reduce the risk of toxicity, and (iii) overexpressed in tumors as compared to the normal tissues. Here we argue that p62 (SQSTM1), a protein involved in autophagy and signal transduction, fits all the above criteria and can be chosen as a novel cancer antigen. Accordingly, we carried out an extensive study and found antitumor and antimetastatic activity of p62-encoding DNA vaccine in five types of commonly used transplantable tumor models of mice and rats, and spontaneous tumors in several dogs. Given that toxicity of p62 vaccine was minimal, if any, we believe that p62-encoding vaccine merits further clinical development.
登录
查看更多内容
DOI:
10.1038/nrg2432
发表时间:
2008-10
期刊:
Nature reviews. Genetics
影响因子:
--
作者:
通讯作者:
--
影响因子:
16
作者:
Kirkin, Vladimir;Lamark, Trond;Johansen, Terje
通讯作者:
Johansen, Terje
影响因子:
50.3
作者:
Duran, Angeles;Linares, Juan F.;Moscat, Jorge
通讯作者:
Moscat, Jorge
影响因子:
4.8
作者:
Jain, Ashish;Lamark, Trond;Johansen, Terje
通讯作者:
Johansen, Terje
影响因子:
2.8
作者:
Chang, Megan A.;Morgado, Micaela;Delk, Nikki A.
通讯作者:
Delk, Nikki A.